Kidney Research and Clinical Practice

Korean Society of Nephrology (대한신장학회)
권호 표지
DOI QR코드

DOI QR Code

Brain consequences of acute kidney injury: Focusing on the hippocampus

  • Malek, Maryam (Department of Physiology, School of Medicine, Isfahan University of Medical Sciences)
  • Received : 2018.06.07
  • Accepted : 2018.07.31
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

The high mortality rates associated with acute kidney injury are mainly due to extra-renal complications that occur following distant-organ involvement. Damage to these organs, which is commonly referred to as multiple organ dysfunction syndrome, has more severe and persistent effects. The brain and its sub-structures, such as the hippocampus, are vulnerable organs that can be adversely affected. Acute kidney injury may be associated with numerous brain and hippocampal complications, as it may alter the permeability of the blood-brain barrier. Although the pathogenesis of acute uremic encephalopathy is poorly understood, some of the underlying mechanisms that may contribute to hippocampal involvement include the release of multiple inflammatory mediators that coincide with hippocampus inflammation and cytotoxicity, neurotransmitter derangement, transcriptional dysregulation, and changes in the expression of apoptotic genes. Impairment of brain function, especially of a structure that has vital activity in learning and memory and is very sensitive to renal ischemic injury, can ultimately lead to cognitive and functional complications in patients with acute kidney injury. The objective of this review was to assess these complications in the brain following acute kidney injury, with a focus on the hippocampus as a critical region for learning and memory.

Keywords

References

  1. Malek M, Nematbakhsh M. The preventive effects of diminazene aceturate in renal ischemia/reperfusion injury in male and female rats. Adv Prev Med 2014:740647, 2014
  2. Chang CH, Fan PC, Chang MY, et al. Acute kidney injury enhances outcome prediction ability of sequential organ failure assessment score in critically ill patients. PLoS One 9:e109649, 2014 https://doi.org/10.1371/journal.pone.0109649
  3. Malek M, Nematbakhsh M. Renal ischemia/reperfusion injury; from pathophysiology to treatment. J Renal Inj Prev 4:20-27, 2015
  4. Yap SC, Lee HT. Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence. Anesthesiology 116:1139-1148, 2012 https://doi.org/10.1097/ALN.0b013e31824f951b
  5. Chertow GM, Lazarus JM, Paganini EP, Allgren RL, Lafayette RA, Sayegh MH. Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group. J Am Soc Nephrol 9:692-698, 1998
  6. Malek M, Hassanshahi J, Fartootzadeh R, Azizi F, Shahidani S. Nephrogenic acute respiratory distress syndrome: a narrative review on pathophysiology and treatment. Chin J Traumatol 21:4-10, 2018 https://doi.org/10.1016/j.cjtee.2017.07.004
  7. Kelly KJ. Acute renal failure: much more than a kidney disease. Semin Nephrol 26:105-113, 2006 https://doi.org/10.1016/j.semnephrol.2005.09.003
  8. Doi K, Rabb H. Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targets. Kidney Int 89:555-564, 2016 https://doi.org/10.1016/j.kint.2015.11.019
  9. Vanholder R, Pletinck A, Schepers E, Glorieux G. Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update. Toxins (Basel ) 10:pii: E33, 2018
  10. Hoke TS, Douglas IS, Klein CL, et al. Acute renal failure after bilateral nephrectomy is associated with cytokinemediated pulmonary injury. J Am Soc Nephrol 18:155-164, 2007 https://doi.org/10.1681/ASN.2006050494
  11. Rabb H, Wang Z, Nemoto T, Hotchkiss J, Yokota N, Soleimani M. Acute renal failure leads to dysregulation of lung salt and water channels. Kidney Int 63:600-606, 2003 https://doi.org/10.1046/j.1523-1755.2003.00753.x
  12. Karimi Z, Ketabchi F, Alebrahimdehkordi N, Fatemikia H, Owji SM, Moosavi SM. Renal ischemia/reperfusion against nephrectomy for induction of acute lung injury in rats. Ren Fail 38:1503-1515, 2016 https://doi.org/10.1080/0886022X.2016.1214149
  13. Hassoun HT, Grigoryev DN, Lie ML, et al. Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy. Am J Physiol Renal Physiol 293:F30-F40, 2007 https://doi.org/10.1152/ajprenal.00023.2007
  14. Chi OZ, Hunter C, Liu X, Tan T, Weiss HR. Effects of VEGF on the blood-brain barrier disruption caused by hyperosmolarity. Pharmacology 82:187-192, 2008 https://doi.org/10.1159/000151433
  15. Sadik NA, Mohamed WA, Ahmed MI. The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis. Mol Cell Biochem 359:73-81, 2012 https://doi.org/10.1007/s11010-011-1001-4
  16. Burn DJ, Bates D. Neurology and the kidney. J Neurol Neurosurg Psychiatry 65:810-821, 1998 https://doi.org/10.1136/jnnp.65.6.810
  17. De Deyn PP, Saxena VK, Abts H, et al. Clinical and pathophysiological aspects of neurological complications in renal failure. Acta Neurol Belg 92:191-206, 1992
  18. Chou AH, Lee CM, Chen CY, et al. Hippocampal transcriptional dysregulation after renal ischemia and reperfusion. Brain Res 1582:197-210, 2014 https://doi.org/10.1016/j.brainres.2014.07.030
  19. Fukunishi I, Kitaoka T, Shirai T, Kino K, Kanematsu E, Sato Y. Psychiatric disorders among patients undergoing hemodialysis therapy. Nephron 91:344-347, 2002 https://doi.org/10.1159/000058418
  20. Liu M, Liang Y, Chigurupati S, et al. Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol 19:1360-1370, 2008 https://doi.org/10.1681/ASN.2007080901
  21. Serlin Y, Shelef I, Knyazer B, Friedman A. Anatomy and physiology of the blood-brain barrier. Semin Cell Dev Biol 38:2-6, 2015 https://doi.org/10.1016/j.semcdb.2015.01.002
  22. Ratliff BB, Rabadi MM, Vasko R, Yasuda K, Goligorsky MS. Messengers without borders: mediators of systemic inflammatory response in AKI. J Am Soc Nephrol 24:529-536, 2013 https://doi.org/10.1681/ASN.2012060633
  23. Patel JP, Frey BN. Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder? Neural Plast 2015:708306, 2015
  24. Fleegal-DeMotta MA, Doghu S, Banks WA. Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells. J Cereb Blood Flow Metab 29:640-647, 2009 https://doi.org/10.1038/jcbfm.2008.158
  25. Biancardi VC, Stern JE. Compromised blood-brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension. J Physiol 594:1591-1600, 2016 https://doi.org/10.1113/JP271584
  26. Davis CJ, Kramar E, De A, et al. AT4 receptor activation increases intracellular calcium influx and induces a non-Nmethyl-D-aspartate dependent form of long-term potentiation. Neuroscience 137:1369-1379, 2006 https://doi.org/10.1016/j.neuroscience.2005.10.051
  27. von Bohlen und Halbach O, Albrecht D. Mapping of angiotensin AT1 receptors in the rat limbic system. Regul Pept 78:51-56, 1998 https://doi.org/10.1016/S0167-0115(98)00109-8
  28. AbdAlla S, Lother H, el Missiry A, et al. Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. J Biol Chem 284:6554-6565, 2009 https://doi.org/10.1074/jbc.M807746200
  29. Labandeira-Garcia JL, Rodriguez-Perez AI, Garrido-Gil P, Rodriguez-Pallares J, Lanciego JL, Guerra MJ. Brain reninangiotensin system and microglial polarization: implications for aging and neurodegeneration. Front Aging Neurosci 9:129, 2017 https://doi.org/10.3389/fnagi.2017.00129
  30. Pan HL. Brain angiotensin II and synaptic transmission. Neuroscientist 10:422-431, 2004 https://doi.org/10.1177/1073858404264678
  31. Wei SG, Zhang ZH, Beltz TG, Yu Y, Johnson AK, Felder RB. Subfornical organ mediates sympathetic and hemodynamic responses to blood-borne proinflammatory cytokines. Hypertension 62:118-125, 2013 https://doi.org/10.1161/HYPERTENSIONAHA.113.01404
  32. Konsman JP, Vigues S, Mackerlova L, Bristow A, Blomqvist A. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J Comp Neurol 472:113-129, 2004 https://doi.org/10.1002/cne.20052
  33. Jeong EG, Nam HS, Lee SM, An WS, Kim SE, Son YK. Role of B-type natriuretic peptide as a marker of mortality in acute kidney injury patients treated with continuous renal replacement therapy. Ren Fail 35:1216-1222, 2013 https://doi.org/10.3109/0886022X.2013.823870
  34. Chauhan SD, Nilsson H, Ahluwalia A, Hobbs AJ. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci U S A 100:1426-1431, 2003 https://doi.org/10.1073/pnas.0336365100
  35. Costa MD, Bosc LV, Majowicz MP, Vidal NA, Balaszczuk AM, Arranz CT. Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats. Hypertension 35:1119-1123, 2000 https://doi.org/10.1161/01.HYP.35.5.1119
  36. Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev 61:62-97, 2009 https://doi.org/10.1124/pr.108.000547
  37. Leaf DE, Waikar SS, Wolf M, Cremers S, Bhan I, Stern L. Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes. Clin Endocrinol (Oxf) 79:491-498, 2013 https://doi.org/10.1111/cen.12172
  38. Haycock GB. Management of acute and chronic renal failure in the newborn. Semin Neonatol 8:325-334, 2003 https://doi.org/10.1016/S1084-2756(03)00044-7
  39. Zhang M, Hsu R, Hsu CY, et al. FGF-23 and PTH levels in patients with acute kidney injury: a cross-sectional case series study. Ann Intensive Care 1:21, 2011 https://doi.org/10.1186/2110-5820-1-21
  40. Lourida I, Thompson-Coon J, Dickens CM, et al. Parathyroid hormone, cognitive function and dementia: a systematic review. PLoS One 10:e0127574, 2015 https://doi.org/10.1371/journal.pone.0127574
  41. Scaini G, Ferreira GK, Streck EL. Mechanisms underlying uremic encephalopathy. Rev Bras Ter Intensiva 22:206-211, 2010 https://doi.org/10.1590/S0103-507X2010000200016
  42. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46-56, 2008 https://doi.org/10.1038/nrn2297
  43. D'Mello C, Swain MG. Liver-brain inflammation axis. Am J Physiol Gastrointest Liver Physiol 301:G749-G761, 2011 https://doi.org/10.1152/ajpgi.00184.2011
  44. Riazi K, Galic MA, Kentner AC, Reid AY, Sharkey KA, Pittman QJ. Microglia-dependent alteration of glutamatergic synaptic transmission and plasticity in the hippocampus during peripheral inflammation. J Neurosci 35:4942-4952, 2015 https://doi.org/10.1523/JNEUROSCI.4485-14.2015
  45. Hu H, Ho W, Mackie K, Pittman QJ, Sharkey KA. Brain $CB_{1}$ receptor expression following lipopolysaccharide-induced inflammation. Neuroscience 227:211-222, 2012 https://doi.org/10.1016/j.neuroscience.2012.09.067
  46. Watson CP, Pazarentzos E, Fidanboylu M, Padilla B, Brown R, Thomas SA. The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and Larginine with the human blood-brain barrier in vitro. Brain Res 1648:232-242, 2016 https://doi.org/10.1016/j.brainres.2016.07.026
  47. Adachi N, Lei B, Deshpande G, et al. Uraemia suppresses central dopaminergic metabolism and impairs motor activity in rats. Intensive Care Med 27:1655-1660, 2001 https://doi.org/10.1007/s001340101067
  48. Zhang N, Cheng GY, Liu XZ, Zhang FJ. Expression of Bcl- 2 and $NF-{\kappa}B$ in brain tissue after acute renal ischemiareperfusion in rats. Asian Pac J Trop Med 7:386-389, 2014 https://doi.org/10.1016/S1995-7645(14)60061-4
  49. Karimi N, Haghani M, Noorafshan A, Moosavi SMS. Structural and functional disorders of hippocampus following ischemia/reperfusion in lower limbs and kidneys. Neuroscience 358:238-248, 2017 https://doi.org/10.1016/j.neuroscience.2017.06.058
  50. Tahamtan M, Moosavi SM, Sheibani V, Nayebpour M, Esmaeili-Mahani S, Shabani M. Erythropoietin attenuates motor impairments induced by bilateral renal ischemia/reperfusion in rats. Fundam Clin Pharmacol 30:502-510, 2016 https://doi.org/10.1111/fcp.12226
  51. Elias MF, Elias PK, Seliger SL, Narsipur SS, Dore GA, Robbins MA. Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant 24:2446-2452, 2009 https://doi.org/10.1093/ndt/gfp107
  52. Tsai HH, Yen RF, Lin CL, Kao CH. Increased risk of dementia in patients hospitalized with acute kidney injury: a nationwide population-based cohort study. PLoS One 12:e0171671, 2017 https://doi.org/10.1371/journal.pone.0171671
  53. Barzilay JI, Gao P, O'Donnell M; ONTARGET and TRANSCEND Investigators, et al. Albuminuria and decline in cognitive function: the ONTARGET/TRANSCEND studies. Arch Intern Med 171:142-150, 2011 https://doi.org/10.1001/archinternmed.2010.502
  54. Tahamtan M, Sheibani V, Shid Moosavi SM, et al. Pretreatment with erythropoietin attenuates bilateral renal ischemia-induced cognitive impairments. Iran J Pharm Res 17:601-612, 2018
  55. Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol 24:353-363, 2013 https://doi.org/10.1681/ASN.2012050536

Cited by

  1. Relation of Poor Nutritional Status to Mild Cognitive Impairment in Patients with Coronary Artery Disease vol.24, pp.10, 2018, https://doi.org/10.1007/s12603-020-1428-y
  2. Alteration of brain connectivity in neurologically asymptomatic patients with chronic kidney disease vol.100, pp.16, 2018, https://doi.org/10.1097/md.0000000000025633
  3. Renal Replacement Therapy and Dialysis-associated Neurovascular Injury (DANI) in the Neuro ICU: a Review of Pathophysiology and Preventative Options vol.23, pp.2, 2018, https://doi.org/10.1007/s11940-020-00661-1
  4. Association of Acute Kidney Injury with the Risk of Dementia: A Meta-Analysis vol.10, pp.19, 2021, https://doi.org/10.3390/jcm10194390
  5. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline vol.21, pp.1, 2018, https://doi.org/10.1159/000518581